HRMY - Financial Reports List - Harmony Biosciences Holdings, Inc. - IntrinsicAlpha

Harmony Biosciences Holdings, Inc. HRMY

Healthcare - Biotechnology - NASDAQ - US

$ 28.93

0.141 %

$ 1.66 B

Market Cap

11.35

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	19.51%	85.95%	38.64%
Annual Report	FY	10-K	2024-12-31	22.80%	12.91%	-0.63%
Quarterly Report	Q3	8-K	2024-09-30	16.08%	19.84%	-4.34%
Quarterly Report	Q2	8-K	2024-06-30	28.76%	-66.21%	-54.47%
Quarterly Report	Q1	8-K	2024-03-31	29.79%	30.01%	28.72%
Quarterly Report	Q4	8-K	2023-12-31	31.26%	-45.15%	-15.58%
Annual Report	FY	10-K	2023-12-31	32.93%	-28.99%	59.78%
Quarterly Report	Q3	8-K	2023-09-30	36.74%	-56.27%	442.05%
Quarterly Report	Q2	8-K	2023-06-30	25.40%	45.77%	41.63%
Quarterly Report	Q1	8-K	2023-03-31	39.63%	37.24%	46.69%

1